Jake Baumann

Full HUGE* If True episode on Neuralink and the future of brain computer interfaces I toured @neuralink and got a close up view of their new R1 surgical robot, to see the future they and @elonmusk are building and how it is already changing lives... 00:00 What if you put a chip in your brain? 01:02 What does a human brain feel like? 02:17 How does your brain work? 03:58 Can a brain computer interface read your thoughts? 05:19 How do you get a chip into your brain? 08:07 What’s inside Neuralink’s implant? 10:06 How do you build a brain implant? 11:07 How does robot do brain surgery? 12:20 What could you do with a brain chip? 15:05 How are brain computer interfaces already being used today? 16:07 How are brain chips huge if true?

Introducing Brush: Our first vision-language model for design. 🖌️ Brush sees your design’s layout, layers and vibe the way you do, and edits alongside you. Fix one line of text, restyle a whole deck or build from a blank page. See what Brush can do 👇

Introducing Reality-Aware Rendering in @Simulon, a completely new way to create with the real world. Place neural assets with your phone and act out the scene. When you stop recording, Simulon renders the take, reading everything in it (what you do, what you say and the place around you), and your assets respond to all of it. The final is regenerated from your recording: a new performance of the scene, not a copy of the footage. Available now on iPhone. Coming to Android soon.

Who actually gets rich if Anthropic lists at $2 trillion? The S-1 filed on Monday lets us answer from the filing itself. The reported target is $1.5T to $2T, listing the week of November 16. The filing implies about 16.9B fully diluted shares. So $2T works out to roughly $118 a share. The cap table at $2T: - $199B for the 7 controlling co-founders, about 10% - $28B for Ben Mann, if his stake matches theirs - $100B for the Anthropic Public Benefit Fund, 5% - $331B in employee options and RSUs, about 17% , That pool covers about 5,300 employees, an average of $62M each. - But when you joined matters enormously. The S-1 shows how much equity was granted each year, and at what price. [ Headcount went from about 300 to 500 in late 2023, to 940 at end 2024, to 5,300 now. Match the two, and here is roughly how many people made what at $2T: - $110M to $400M each: ~300 to 500 people hired by 2023 - $200M to $300M each: ~440 to 640 hired in 2024 - $70M to $95M each: ~1,360 hired in 2025 - $10M to $20M each: ~3,000 hired in 2026 So about 940 people hired by the end of 2024 average nine figures. Everyone hired since averages eight figures. The 2024 class is the surprise. That year Anthropic granted 1.28B options at $1.30 a share. At $118, that one year of grants is worth about $133B. Then there is the tender. In April, holders could sell at $25.91 a share. Investors lined up $6B, but only $4.7B sold. Weeks later, Series H priced at $58.90 a share. At $2T, the people who held would be up 4.6x. And Dario and Daniela Amodei were among the sellers. The 7 founders have pledged 80% of their equity to charity. That is about $159B at $2T. But the S-1 says the pledges are not legally binding.

This is Genie 4, our most realistic and interactive world model yet. 🌐 Explore dynamic environments in real time to see how the scene responds, sounds, and how the people in it move, react, and speak.

Quest Diagnostics has been hacked. Patient data was exposed. They serve roughly half of U.S. hospitals and physicians. Investigation ongoing.

Introducing Demonstration House 2. Our first home built with our completely redesigned building system, engineered for automated manufacturing and rapid assembly. Demo 2 – Proto Town, TX - 2 Bed - 1.5 Bath - 1 Office nook - 1,100 sqft How we got here... 🧵

GPT-Rosalind surfaced a new lead for drug discovery: could restoring cholesterol transport protect neurons from degeneration? DCTN1 is a gene linked to Perry syndrome, a rare neurodegenerative disorder. In mouse-brain data, disrupting it increased expression of genes involved in making cholesterol. GPT-Rosalind suggested a possible explanation: cholesterol may not be reaching where neurons need it. That gives scientists a specific mechanism to test and, if confirmed, a direction for developing new treatments for neurodegenerative disorders. With @perturbai_tx and @scrippsresearch, a team of thousands of GPT-Rosalind agents worked in parallel, connecting gene-expression results from millions of mouse brain cells with scientific literature in just 32 minutes. We’re now expanding this collaboration to identify new drug targets. openai.com/index/scaling-ai-…

Last month, we demonstrated high-rate alchemy: turning mercury into real, stable gold, beating CERN’s record by a factor of 10. Last week, we enriched isotopes in the world’s most powerful plasma centrifuge, beating the Soviet record that stood for 40 years. Now, we’re building a fusion reactor in San Francisco to achieve record power density.

We're hosting a poker night for consumer app founders + growth leads in SF 🃏 Wed 10/28 · 7 PM · Union Square Free to enter. Winner gets Ray-Ban Meta Gen 3s 😎 No pitches, just poker. Limited seats. Apply here: luma.com/7zg5lb5j?utm_source…